Sponsor of the Day:
Jerkmate
https://www.sygnaturediscovery.com/in-vivo-pharmacology/ex-vivo-tissue-analysis/
ex vivo Tissue Analysis - Sygnature
Feb 5, 2026 - Explore our ex vivo tissue analysis support, offering customizable assays for gene expression, protein analysis and immune profiling.
ex vivotissueanalysissygnature
https://manufacturingchemist.com/sygnature-discovery-strengthens-in-vivo-pharmacology-leadership-with
Sygnature Discovery strengthens in vivo pharmacology leadership with appointment of Susanne Back
The appointment of Susanne Back as Head of In Vivo Pharmacology will further strengthen its bioscience leadership and reinforcing its commitment to delivering...
sygnature discoverystrengthensvivopharmacologyleadership
https://careers.sygnaturediscovery.com/
Welcome to our career site - Sygnature Discovery
career sitesygnature discoverywelcome
https://www.sygnaturediscovery.com/resource-hub/technical-notes/
Technical notes - Sygnature
technical notessygnature
https://www.sygnaturediscovery.com/
Sygnature Discovery - Leading Contract Research Organisation
Mar 24, 2026 - Sygnature Discovery is a world-leading integrated drug discovery CRO based in the UK and Canada with headquarters in Nottingham (UK).
sygnature discoverycontract researchleadingorganisation
https://www.sygnaturediscovery.com/computer-aided-drug-design/admet-predictions/
ADMET Prediction Software - Sygnature
Feb 10, 2026 - ADMET Prediction Software is valuable in late-stage drug discovery for addressing persistent ADMET liability in lead series.
prediction softwareadmetsygnature
https://www.sygnaturediscovery.com/integrated-drug-discovery/
Integrated Drug Discovery - Sygnature
Feb 12, 2026 - Integrated drug discovery with Sygnature’s multidisciplinary teams. From target to candidate, delivering speed and decision-ready data.
integrated drug discoverysygnature
https://www.sygnaturediscovery.com/therapeutic-areas/oncology/
Oncology and Immuno-Oncology Drug Discovery - Sygnature
Feb 11, 2026 - Sygnature Discovery works right across oncology drug discovery, from target ID and lead op to candidate nomination and clinical positioning.
drug discovery sygnatureoncologyimmuno
https://www.sygnaturediscovery.com/in-vivo-pharmacology/oncology-models/
Oncology Models - Sygnature
oncologymodelssygnature
https://www.sygnaturediscovery.com/therapeutic-areas/neuroscience/
Neuroscience Drug Discovery - Sygnature
Feb 11, 2026 - Elevate neuroscience drug discovery with Sygnature: tailored strategies, advanced assays, and in-vivo models for CNS success.
drug discovery sygnatureneuroscience
https://www.sygnaturediscovery.com/about-us/our-team/
Our Team - Sygnature
teamsygnature
https://www.sygnaturediscovery.com/form-formulation/polymorph-screening/
Polymorph Screening - Sygnature
Feb 10, 2026 - Advanced Polymorph Screening for Drug Development at Sygnature Discovery, leveraging thermodynamics and analytics to identify stable forms.
polymorphscreeningsygnature
https://www.sygnaturediscovery.com/sygnature-discovery-completes-major-enhancement-of-high-throughput-chemistry-facilities-following-1-million-investment-2/
Sygnature Discovery Completes Major Enhancement of High-Throughput Chemistry Facilities Following...
sygnature discoverycompletes majorhigh throughputenhancementchemistry
https://www.sygnaturediscovery.com/case-study/sitryx-empowering-new-ideas-2
Sitryx: Empowering New Ideas - Sygnature
Feb 5, 2026 - Discover how Sygnature Discovery supported Sitryx transform scientific concepts into candidate molecules and securing major pharma investment.
empowering newideassygnature